Literature DB >> 15080182

Role of neutralizing antibodies in HIV infection.

Nancy L Haigwood1, Leonidas Stamatatos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 15080182     DOI： 10.1097/00002030-200317004-00008

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  14 in total

1.  Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.

Authors:  Jeffrey D Lifson; Nancy L Haigwood
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

2.  Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis.

Authors:  Ralph Pantophlet; Rowena O Aguilar-Sino; Terri Wrin; Lisa A Cavacini; Dennis R Burton
Journal:  Virology       Date:  2007-04-06       Impact factor: 3.616

3.  Neutralization of HIV-1 by redirection of natural antibodies.

Authors:  Maria F Perdomo; Michael Levi; Matti Sällberg; Anders Vahlne
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

4.  The antigenic determinants on HIV p24 for CD4+ T cell inhibiting antibodies as determined by limited proteolysis, chemical modification, and mass spectrometry.

Authors:  Jason G Williams; Kenneth B Tomer; Catarina E Hioe; Susan Zolla-Pazner; Philip J Norris
Journal:  J Am Soc Mass Spectrom       Date:  2006-07-27       Impact factor: 3.109

5.  Human immunodeficiency virus type 1 variants isolated from single plasma samples display a wide spectrum of neutralization sensitivity.

Authors:  Katharina Skrabal; Sentob Saragosti; Jean-Louis Labernardière; Francis Barin; François Clavel; Fabrizio Mammano
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Influence of glycosylation on the efficacy of an Env-based vaccine against simian immunodeficiency virus SIVmac239 in a macaque AIDS model.

Authors:  Kazuyasu Mori; Chie Sugimoto; Shinji Ohgimoto; Emi E Nakayama; Tatsuo Shioda; Shigeru Kusagawa; Yutaka Takebe; Munehide Kano; Tetsuro Matano; Takae Yuasa; Daisuke Kitaguchi; Masaaki Miyazawa; Yumiko Takahashi; Michio Yasunami; Akinori Kimura; Naoki Yamamoto; Yasuo Suzuki; Yoshiyuki Nagai
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected Senegalese patients: distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infections.

Authors:  Shaun K Rodriguez; Abdoulaye Dieng Sarr; Adam MacNeil; Seema Thakore-Meloni; Aissatou Gueye-Ndiaye; Ibrahima Traoré; Mamadou C Dia; Souleymane Mboup; Phyllis J Kanki
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

8.  Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10.

Authors:  Akram A Da'dara; Donald A Harn
Journal:  Vaccine       Date:  2009-11-24       Impact factor: 3.641

9.  An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions.

Authors:  Joseph G Joyce; Isaac J Krauss; Hong C Song; David W Opalka; Karen M Grimm; Deborah D Nahas; Mark T Esser; Renee Hrin; Meizhen Feng; Vadim Y Dudkin; Michael Chastain; John W Shiver; Samuel J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-06       Impact factor: 11.205

10.  Antibody-Dependent Cellular Cytotoxicity and NK Cell-Driven Immune Escape in HIV Infection: Implications for HIV Vaccine Development.

Authors:  Gamze Isitman; Ivan Stratov; Stephen J Kent
Journal:  Adv Virol       Date:  2012-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.